https://www.globenewswire.com/fr/news-release/2026/02/21/3242195/0/en/rakovina-therapeutics-announces-upsized-financing-up-to-2-0-million.html
Rakovina Therapeutics Announces Upsized Financing Up to
Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share Private Placement Up to $1.0 Million Intended to Support...
rakovinatherapeuticsannouncesfinancing
https://www.globenewswire.com/de/news-release/2026/03/23/3260146/0/en/Rakovina-Therapeutics-to-Present-New-Data-at-the-AACR-Annual-Meeting-2026-World-s-Premier-Cancer-Research-Forum.html
Rakovina Therapeutics to Present New Data at the AACR
Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline...
new datarakovinatherapeuticspresentaacr
https://www.biospace.com/press-releases/rakovina-therapeutics-announces-strategic-private-placement-convertible-debt-financing-and-share-consolidation-to-accelerate-us-focused-growth-and-ai-powered-oncology-innovation
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share...
private placementconvertible debtrakovinatherapeuticsannounces
https://www.globenewswire.com/de/news-release/2025/12/01/3196721/0/en/Rakovina-Therapeutics-Announces-Three-Month-Q3-ended-September-30-2025-Financial-Results-and-Provides-Corporate-Update.html
Rakovina Therapeutics Announces Three-Month Q3 ended
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rakovina...
rakovinatherapeuticsannouncesthreemonth
https://www.globenewswire.com/de/news-release/2026/01/27/3227046/0/en/Rakovina-Therapeutics-Announces-Corporate-Update-Including-up-to-1-5-Million-in-New-Financing-Leadership-Appointments-and-Debt-Restructuring.html
Rakovina Therapeutics Announces Corporate Update Including
Proposed $1.0 million Convertible Debenture and concurrent $500,000 Private Placement Intended to Support Near-Term Operations Board and Management...
corporate updaterakovinatherapeuticsannouncesincluding
https://investingnews.com/rakovina-therapeutics-cso-dr-mads-daugaard-invited-to-present-at-the-13th-tuscany-retreat-on-cancer-research-and-apoptosis/
Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on...
Sep 9, 2025 - Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered...
https://www.globenewswire.com/fr/news-release/2026/03/23/3260146/0/en/Rakovina-Therapeutics-to-Present-New-Data-at-the-AACR-Annual-Meeting-2026-World-s-Premier-Cancer-Research-Forum.html
Rakovina Therapeutics to Present New Data at the AACR
Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline...
new datarakovinatherapeuticspresentaacr
https://www.fiercebiotech.com/biotech/rakovina-deepens-ai-focus-cancer-collab-select-dna-damage-response-kinase-targets
Rakovina deepens AI focus with collab to select cancer targets
Sep 17, 2024 - Five months after Rakovina Therapeutics pivoted toward artificial intelligence, the cancer-focused biotech has joined forces with Variational AI to identify...
ai focusrakovinacollabselectcancer
https://investingnews.com/rakovina-therapeutics-announces-extension-of-non-brokered-private-placement/
Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement | INN
Mar 12, 2026 - Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer therapies through...
private placementrakovinatherapeuticsannouncesextension
https://investingnews.com/rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting/
Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting | INN
Apr 22, 2026 - Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence...
2026 annual meeting
https://www.globenewswire.com/de/news-release/2025/12/10/3202942/0/en/Rakovina-Therapeutics-Announces-Upcoming-Webinar-with-Variational-AI.html
Rakovina Therapeutics Announces Upcoming Webinar with
upcoming webinarrakovinatherapeuticsannounces
https://www.biospace.com/rakovina-therapeutics-announces-debentureholder-election-to-receive-shares-in-partial-satisfaction-of-debenture-interest-payment-obligations
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction...
May 27, 2024 - Rakovina Therapeutics Inc. announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust Company dated May 29,...
rakovinatherapeuticsannounceselection
https://www.globenewswire.com/news-release/2025/12/10/3202942/0/en/rakovina-therapeutics-announces-upcoming-webinar-with-variational-ai.html
Rakovina Therapeutics Announces Upcoming Webinar with
upcoming webinarrakovinatherapeuticsannounces
https://www.nasdaq.com/market-activity/stocks/rkvtf
RAKOVINA THERAPEUTICS INC (RKVTF) Stock Price, Quote, News & History | Nasdaq
Discover real-time RAKOVINA THERAPEUTICS INC (RKVTF) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions....
stock pricenews historyrakovinatherapeuticsinc
https://www.nasdaq.com/market-activity/stocks/rkvtf/historical
RAKOVINA THERAPEUTICS INC (RKVTF) Historical Data | Nasdaq
Find the latest historical data for RAKOVINA THERAPEUTICS INC (RKVTF) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.
historical datarakovinatherapeuticsincnasdaq
https://www.globenewswire.com/news-release/2025/05/15/3082703/0/en/Rakovina-Therapeutics-Announces-Strategic-Private-Placement-Convertible-Debt-Financing-and-Share-Consolidation-to-Accelerate-US-Focused-Growth-and-AI-Powered-Oncology-Innovation.html
Rakovina Therapeutics Announces Strategic Private
$3 Million Lead Order from Strategic Investors Supports Bold Transformation...
rakovinatherapeuticsannouncesstrategicprivate
https://www.globenewswire.com/de/news-release/2025/12/10/3202942/0/en/rakovina-therapeutics-announces-upcoming-webinar-with-variational-ai.html
Rakovina Therapeutics Announces Upcoming Webinar with
upcoming webinarrakovinatherapeuticsannounces
https://investingnews.com/rakovina-therapeutics-to-present-new-data-at-the-aacr-annual-meeting-2026-world-s-premier-cancer-research-forum/
Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer...
Mar 23, 2026 - Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence...
https://investingnews.com/rakovina-therapeutics-inc-announces-2025-financial-results-and-provides-corporate-update/
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update | INN
May 1, 2026 - Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7J0), a biopharmaceutical company advancing next-generation cancer therapies...
2025 financial results
https://investingnews.com/rakovina-announces-closing-of-1-million-debenture-unit-private-placement-and-debt-settlement-agreements/
Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement...
Mar 6, 2026 - Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer therapies through...
https://www.sofi.com/invest/stock/RKVTF/
Buy RAKOVINA THERAPEUTICS INC by RAKOVINA THERAPEUTICS INC Stock - RKVTF Stock Price, Quote & News...
See real time price charts for RKVTF stock, historical data, and recent news. Buy RKVTF stock online with no commission fees.
by stockprice quotebuyrakovinatherapeutics
https://investingnews.com/rakovina-therapeutics-and-nanopalm-ltd-sign-letter-of-intent-to-form-joint-venture-leveraging-ai-discovered-oncology-therapies-and-novel-lipid-nanoparticle-delivery-technologies/
Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging...
Sep 9, 2025 - Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through artificial...